Almac clinical trial workshop series returns in 2013

Published: 20-Mar-2013 Featured companies: Almac Group
Regulatory

Interactive workshops are intended for clinical trial/outsourcing professionals from pharmaceutical and biotech companies


The Almac Group is hosting its third international series of complimentary workshops this spring, entitled ‘Protocol to Patient: Managing Clinical Supplies in an Evolving Marketplace’.

The day-long, interactive workshops are intended for clinical trial/outsourcing professionals from pharmaceutical and biotech companies. Their goal is to introduce and propose strategies for successful clinical supply chain management, ranging from packing design considerations to global distribution.

The workshops will divide attendees into three groups, each one a different component of supply chain management. Speakers will present case studies that examine issues related to clinical supply management, and all three groups - a CRO, a clinical technology services company and a study sponsor - will approach the case study issues and devise solutions based on their assigned point of view.

Robert Dunlop, Managing Director at Almac Clinical Services, commented: ‘The workshops are designed to foster learning, build networks, and promote professional development among those in all facets of the clinical trial profession. We encourage attendees to discuss common challenges and brainstorm solutions, and hope they will take away new or improved processes that will lead to greater success.’

The venues and dates are as follows:

  • Copenhagen, Denmark: Palace Hotel, Tuesday 23 April
  • Cambridge, UK: Trinity Centre, Thursday 25 April
  • Basel, Switzerland: Swissotel, Tuesday 7 May
  • Frankfurt, Germany: Sheraton Congress, Thursday 9 May
  • Boston, MA, USA: Hotel Marlow, Tuesday 14 May
  • San Francisco, CA, USA: Hilton San Francisco Airport Bayfront, Thursday 16 May
  • Durham, NC, USA: The Solution Center, Tuesday 21 May
  • New Brunswick, NJ, USA: The Heldrich, Tuesday 24 May

To register for an event near you, visit the registration sites here. Seats are limited and registration is required to secure your place.

Featured companies

See more

You may also like

Manufacturing

Almac completes “outstanding” grade by the KTP

Read more
The Innovate UK-funded KTP aimed to embed flow technologies to ensure long term security of supply for key raw materials through development

Trending Articles

  1. Overcoming CMC challenges in cell and gene therapy: part I Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
  2. The rising importance of preservative efficacy testing When considering the regulation and validation of pharmaceutical products, the efficacy of the active pharmaceutical ingredient (API) is often the main concern
  3. Tagrisso receives full approval in the EU For patients with locally-advanced or metastatic EGFR T790M mutation-positive non-small cell lung cancer
  4. AskBio receives FDA Fast Track Designation for congestive heart failure gene therapy programme The fast-tracking allows the development and expedition of review processes for AB-1002, a gene therapy to promote production of a constituently active form of I-1c
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena

Relevant companies

See more

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Manufacturing

Almac completes “outstanding” grade by the KTP

The Innovate UK-funded KTP aimed to embed flow technologies to ensure long term security of supply for key raw materials through development
Manufacturing

Almac Sciences Ireland secures HPRA certification

This additional certification enables Almac to perform biologics testing for the determination of product quality attributes
Regulatory

Almac receives product approval by MHRA and Health Canada

The company’s site provides a range of solutions for blister packs, stickpacks, and kitting
Packaging

Enhancing clinical trial supply with JTM: part I

In a constantly changing world, the pharmaceutical industry is having to adopt its practices to serve the needs of a rapidly growing and ageing population and develop innovative personalised medicines. Almac has responded to these demands with a Just-in-Time Manufacturing solution that fulfils the requirements of a high value, time sensitive clinical supply chain. Dr Kevin Robinson spoke to Natalie Balanovsky, Just-in-Time Manufacturing Solutions Manager, and Mark Rohlfing, Vice President of Operations, to find out more
Regulatory

Almac welcomes confirmation that Northern Ireland will remain aligned with the EU post-Brexit

Move offers Almac clients unique, unfettered and flexible access to both the UK and European markets
Regulatory

Almac Group supports two COVID-19 clinical studies in sub-Saharan Africa

Grant awarded from the COVID-19 Therapeutics Accelerator, an Initiative by the Bill & Melinda Gates Foundation, Wellcome and Mastercard
Packaging

Almac Just in Time Manufacturing operations pass EU inspection

The GMP compliance certification is a significant milestone for Almac Clinical Services and its Almac Adapt
Subscribe now